Metagenomi, Inc. Common Stock (MGX) Stock Overview
Explore Metagenomi, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Metagenomi, Inc. Common Stock (MGX)
Key Financials
Key Financials
Market Cap
42.9M
P/E Ratio
-0.46
EPS (TTM)
$-2.49
ROE
-0.64%
MGX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Metagenomi, Inc. Common Stock (NASDAQ: MGX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Metagenomi, Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MGX on the NASDAQ shows an RSI of 43.79, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.94 for the NASDAQ listing.
Key metrics behind Metagenomi, Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -0.46 and a market capitalization of 42.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MGX on the NASDAQ.